Clinical trials are the most costly, time-consuming, and heavily regulated stages in drug development, often costing hundreds of millions of dollars and sometimes exceeding a billion dollars. Every month of delay cuts into the patent-protected window that determines a drug’s commercial viability, with companies losing tens of millions of dollars
Inequities in cancer care cause specific populations in the U.S. and worldwide to bear a more significant burden of disease than the general population, based upon barriers. These barriers to prevention and care have long existed but were undeniably exacerbated by the COVID-19 pandemic. February 4 marks World Cancer Day, which
In my 15+ years working in clinical research, I've not seen significant evolution in the way we do clinical trials and apply advanced analytics to clinical trial data. A personal story demonstrates that a similar problem is at play in health care. Each year my daughter visits the children’s cardiology
I am writing this post with the satisfaction of having Implementing CDISC Using SAS: An End-to-End Guide, Second Edition completed and on the shelf. Once again, it was my pleasure to collaborate with Chris Holland, and I am glad that we had a chance to update the book with current
There was this very embarrassing day around year six of my career as a statistician working in clinical trials. I had a small group of interns working on a project that combined data from multiple clinical trials. The goal was to better understand sources of variation in the common control
There was this very embarrassing day around year six of my career as a statistician working in clinical trials. I had a small group of interns working on a project that combined data from multiple clinical trials. The goal was to better understand sources of variation in the common control
